Literature DB >> 8917365

1 alpha, 25-dihydroxyvitamin D3 and all-trans-retinoic acid inhibit the growth of a lung cancer cell line.

Y Higashimoto1, M Ohata, K Nishio, Y Iwamoto, H Fujimoto, K Uetani, T Suruda, Y Nakamura, M Funasako, N Saijo.   

Abstract

The secosteroid 1 alpha, 25-dihydroxyvitamin D3 (calcitriol) and retinoic acid are the major biologically active metabolites of vitamins D and A, respectively. Their antitumor activity has been observed in several cancer cells in vitro apart from lung cancer cells. The purpose of this study was to examine the possible effects of the agents on lung cancer cell lines. The responses of five lung cancer cell lines to calcitriol or all-transretinoic acid (RA) were assessed by a colorimetric MTT assay. Calcitriol inhibited growth in one of the tested cell lines, i.e. EBC-1 squamous cell carcinoma, dose dependently. RA also exhibited the same effect in EBC-1 cells. However neither agent affected the growth of other lung cancer cell lines. Subsequently we examined the mRNA expression of vitamin D receptor (VDR) and retinoic acid receptor (RAR alpha) in these lung cancer cells by quantitative RT-PCR. EBC-1 cells expressed high levels of mRNA for both VDR and RAR alpha, while other cell lines expressed much lower mRNA levels for the receptors. These data suggest that the growth inhibitory effects of the vitamins are associated with mRNA expression for VDR and RAR alpha.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8917365

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  13 in total

1.  Mitogen-activated protein kinase inhibits 1,25-dihydroxyvitamin D3-dependent signal transduction by phosphorylating human retinoid X receptor alpha.

Authors:  C Solomon; J H White; R Kremer
Journal:  J Clin Invest       Date:  1999-06       Impact factor: 14.808

2.  Vitamin D receptor expression in normal, premalignant, and malignant human lung tissue.

Authors:  Ravi J Menezes; Richard T Cheney; Aliya Husain; Maria Tretiakova; Gregory Loewen; Candace S Johnson; Vijay Jayaprakash; Kirsten B Moysich; Ravi Salgia; Mary E Reid
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-05       Impact factor: 4.254

3.  Epigenetic regulation of vitamin D metabolism in human lung adenocarcinoma.

Authors:  Nithya Ramnath; Ernest Nadal; Chae Kyung Jeon; Juan Sandoval; Justin Colacino; Laura S Rozek; Paul J Christensen; Manel Esteller; David G Beer; So Hee Kim
Journal:  J Thorac Oncol       Date:  2014-04       Impact factor: 15.609

Review 4.  Retinoids: present role and future potential.

Authors:  T R Evans; S B Kaye
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

5.  Circulating 25-hydroxyvitamin D and lung cancer risk and survival: A dose-response meta-analysis of prospective cohort studies.

Authors:  Qianqian Feng; Han Zhang; Zhengqin Dong; Yang Zhou; Jingping Ma
Journal:  Medicine (Baltimore)       Date:  2017-11       Impact factor: 1.817

6.  Sunlight may increase the FDG uptake value in primary tumors of patients with non-small cell lung cancer.

Authors:  Hasan Mutlu; Abdullah Büyükçelik; Eser Kaya; Mustafa Kibar; Ertuğrul Seyrek; Sinan Yavuz; Züleyha Calikuşu
Journal:  Oncol Lett       Date:  2013-01-07       Impact factor: 2.967

7.  Diet-derived 25-hydroxyvitamin D3 activates vitamin D receptor target gene expression and suppresses EGFR mutant non-small cell lung cancer growth in vitro and in vivo.

Authors:  Alissa R Verone-Boyle; Suzanne Shoemaker; Kristopher Attwood; Carl D Morrison; Andrew J Makowski; Sebastiano Battaglia; Pamela A Hershberger
Journal:  Oncotarget       Date:  2016-01-05

8.  Vitamin D derivatives potentiate the anticancer and anti-angiogenic activity of tyrosine kinase inhibitors in combination with cytostatic drugs in an A549 non-small cell lung cancer model.

Authors:  Ewa Maj; Beata Filip-Psurska; Magdalena Milczarek; Mateusz Psurski; Andrzej Kutner; Joanna Wietrzyk
Journal:  Int J Oncol       Date:  2017-12-15       Impact factor: 5.650

9.  Meta-analysis of the correlation between vitamin D and lung cancer risk and outcomes.

Authors:  Jian Liu; Yongquan Dong; Chao Lu; Yina Wang; Ling Peng; Mengjie Jiang; Yemin Tang; Qiong Zhao
Journal:  Oncotarget       Date:  2017-06-28

10.  Inverse association of vitamin D3 levels with lung cancer mediated by genetic variation.

Authors:  Majda Haznadar; Kristopher W Krausz; Ezra Margono; Christopher M Diehl; Elise D Bowman; Soumen Kanti Manna; Ana I Robles; Bríd M Ryan; Frank J Gonzalez; Curtis C Harris
Journal:  Cancer Med       Date:  2018-05-03       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.